Lindbrook Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $97.3K | Buy |
575
+69
| +14% | +$11.7K | 0.01% | 690 |
|
|
2024
Q4 | $76.3K | Buy |
506
+33
| +7% | +$4.98K | 0.01% | 641 |
|
|
2024
Q3 | $73.4K | Buy |
473
+6
| +1% | +$931 | 0.01% | 658 |
|
|
2024
Q2 | $63.9K | Buy |
467
+139
| +42% | +$19K | 0.01% | 698 |
|
|
2024
Q1 | $43.7K | Sell |
328
-87
| -21% | -$11.6K | ﹤0.01% | 827 |
|
|
2023
Q4 | $57.2K | Buy |
415
+227
| +121% | +$31.3K | 0.01% | 711 |
|
|
2023
Q3 | $22.9K | Sell |
188
-45
| -19% | -$5.48K | ﹤0.01% | 1006 |
|
|
2023
Q2 | $32.8K | Sell |
233
-85
| -27% | -$11.9K | ﹤0.01% | 864 |
|
|
2023
Q1 | $45K | Buy |
318
+38
| +14% | +$5.38K | 0.01% | 734 |
|
|
2022
Q4 | $43.8K | Buy |
280
+70
| +33% | +$11K | 0.01% | 743 |
|
|
2022
Q3 | $26K | Sell |
210
-194
| -48% | -$24K | ﹤0.01% | 873 |
|
|
2022
Q2 | $54K | Buy |
404
+32
| +9% | +$4.28K | 0.01% | 626 |
|
|
2022
Q1 | $51K | Buy |
372
+127
| +52% | +$17.4K | 0.01% | 664 |
|
|
2021
Q4 | $42K | Buy |
245
+94
| +62% | +$16.1K | 0.01% | 775 |
|
|
2021
Q3 | $22K | Hold |
151
| – | – | 0.01% | 702 |
|
|
2021
Q2 | $20K | Hold |
151
| – | – | ﹤0.01% | 779 |
|
|
2021
Q1 | $19K | Buy |
151
+4
| +3% | +$503 | ﹤0.01% | 760 |
|
|
2020
Q4 | $18K | Hold |
147
| – | – | ﹤0.01% | 714 |
|
|
2020
Q3 | $17K | Buy |
147
+5
| +4% | +$578 | ﹤0.01% | 667 |
|
|
2020
Q2 | $16K | Sell |
142
-93
| -40% | -$10.5K | ﹤0.01% | 682 |
|
|
2020
Q1 | $19K | Buy |
235
+39
| +20% | +$3.15K | 0.01% | 555 |
|
|
2019
Q4 | $21K | Hold |
196
| – | – | 0.01% | 720 |
|
|
2019
Q3 | $21K | Buy |
196
+42
| +27% | +$4.5K | 0.01% | 691 |
|
|
2019
Q2 | $15K | Hold |
154
| – | – | 0.01% | 771 |
|
|
2019
Q1 | $13K | Hold |
154
| – | – | 0.01% | 810 |
|
|
2018
Q4 | $12K | Buy |
+154
| New | +$12K | 0.01% | 771 |
|